Search by Ticker
Edwards Lifesciences Corporatio (NYSE:EW)
The following stock analysis is based on 9.5 years of data (i.e. since Sep 20, 2013). All the stock history has been downloaded.
Edwards Lifesciences Corporatio trades on the NYSE exchange in USD dollars.
It is in the healthcare sector.
It is currently trading at $81.64 ($80.49 the previous day).
The next reporting date is in 26 days (2023 04 25).
CNN estimates profits for the upcoming quarter will be $0.61 per share ($1.4B). The current Canada / US exchange rate is 1.35644.
Over the past 12 months, $0 worth of shares have been purchased and $43579444 worth of shares have been sold by insiders.
The year over year average increase is 11.7% per year assuming steady exponential growth. The actual 5 year average is 20.98. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||91.757240358744||-16.8||- Below Average|
|2 year||110.28114006849||38||+ Above Average|
|3 year||79.90021618123||13.3||- Below Average|
|4 year||70.538360655738||37.3||+ Above Average|
|5 year||51.380988593156||33.1||+ Above Average|
The worst drop it has had in recent years is -48.0%. It has a steady shape to the stock curve, which means the stock continues on a consistent trend except during extreme periods of volitility, but usually recovers quickly. These stocks are very safe and do not have to be checked often.
Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter. Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.
The company was founded in 1958 and has since grown to 12,200 employees and $3.4 billion in revenue by 2017. Their headquarters is located in Irvine, California (USA). The chairman and CEO is Michael A. Mussallem. The company is part of the S&P500.
Here's Why You Should Retain Avantor (AVTR) Stock for NowTue, 28 Mar 2023 15:40:03 Investors continue to be optimistic about Avantor's (AVTR) strong product portfolio.... Read Full Article
NextGen's (NXGN) New Cloud-Based Solution to Improve WorkflowTue, 28 Mar 2023 15:21:03 NextGen's (NXGN) latest product is expected to simplify connectivity for healthcare providers, thereby solving clinical data exchange challenges.... Read Full Article
Edwards Lifesciences' (NYSE:EW) investors will be pleased with their respectable 79% return over the last five yearsMon, 27 Mar 2023 10:47:15 Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...... Read Full Article
HOLX vs. EW: Which Stock Is the Better Value Option?Thu, 23 Mar 2023 15:40:03 HOLX vs. EW: Which Stock Is the Better Value Option?... Read Full Article
5 big analyst cuts: Tesla stock slumps on Berenberg downgrade | Pro RecapThu, 09 Mar 2023 07:07:57 Tesla (NASDAQ:TSLA) shares fell 3% yesterday after Berenberg downgraded the company to Hold from Buy with a price target of $210.00 (from $200.00) as it believes the upside is limited following the year-to-date outperformance. Long-term, Berenberg remains bullish on the company and ...... Read Full Article
HOLX or EW: Which Is the Better Value Stock Right Now?Tue, 07 Mar 2023 16:40:04 HOLX vs. EW: Which Stock Is the Better Value Option?... Read Full Article
Abbott (ABT) Makes Progress in the TAVI Space With NavitorTue, 07 Mar 2023 14:45:02 Results from Abbott's (ABT) PORTICO study support Navitor's recent FDA approval to treat patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.... Read Full Article
Abbott's (ABT) MitraClip Device Shows Favorable OutcomeTue, 07 Mar 2023 13:03:01 Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.... Read Full Article
EDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME MANAGEMENT OF AORTIC STENOSISMon, 06 Mar 2023 14:00:00 Edwards Lifesciences (NYSE: EW) today highlighted new important data examining mortality rates and cardiac damage of early-stage aortic stenosis (AS) sufferers, along with data examining 10-year transcatheter aortic valve replacement (TAVR) re-intervention rates using real-world Medicare data. Together these studies, ...... Read Full Article
Why Is Edwards Lifesciences (EW) Down 2% Since Last Earnings Report?Thu, 02 Mar 2023 16:30:04 Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.... Read Full Article
Humana (HUM) Exits Business Line to Focus More on Core UnitsMon, 27 Feb 2023 13:55:01 Humana (HUM) will depart from the Employer Group Commercial Medical Products business so that it can invest more funds to grow its core Insurance business lines.... Read Full Article
Zacks Industry Outlook Highlights Edwards Lifesciences, IDEXX Laboratories and HologicFri, 24 Feb 2023 08:13:08 Edwards Lifesciences, IDEXX Laboratories and Hologic have been highlighted in this Industry Outlook article.... Read Full Article
3 Medical Instruments Stocks to Buy Amid Improving Industry TrendsThu, 23 Feb 2023 15:27:03 The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most. Yet, the ongoing inflation, in the form of rising freight, raw material costs, is disrupting the ...... Read Full Article
Edwards Lifesciences (EW) Gains on Innovation, Margin GrowthMon, 20 Feb 2023 15:21:03 In Edwards Lifesciences' (EW) Smart Recovery portfolio, the adoption of FloTrac and ClearSight sensors remains strong.... Read Full Article
With 87% ownership, Edwards Lifesciences Corporation (NYSE:EW) boasts of strong institutional backingSun, 19 Feb 2023 12:20:17 Every investor in Edwards Lifesciences Corporation ( NYSE:EW ) should be aware of the most powerful shareholder groups...... Read Full Article
Interview With David Rolfe of Wedgewood PartnersFri, 17 Feb 2023 20:48:00 David Rolfe is the chief investment officer and portfolio manager at Wedgewood Partners. Under his leadership, Wedgewood was named a separately managed account (SMA) manager of the year in both 2011 and 2013. John Rotonti: Tell us about Wedgewood Partners.... Read Full Article
SONVY or EW: Which Is the Better Value Stock Right Now?Thu, 16 Feb 2023 16:40:04 SONVY vs. EW: Which Stock Is the Better Value Option?... Read Full Article
Select Medical (SEM) Enters JV to Boost New Jersey HealthcareWed, 15 Feb 2023 17:22:05 Select Medical (SEM) collaborates with AtlantiCare to open an inpatient rehabilitation hospital and jointly manage the operations of SEM's outpatient centers across New Jersey.... Read Full Article
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarMon, 13 Feb 2023 14:00:02 Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.... Read Full Article
Is Applied Molecular Transport (AMTI) Stock Outpacing Its Medical Peers This Year?Wed, 08 Feb 2023 14:40:02 Here is how Applied Molecular Transport Inc. (AMTI) and Edwards Lifesciences (EW) have performed compared to their sector so far this year.... Read Full Article